Teleflex Incorporated $TFX Stock: Maryland State Retirement & Pension System Boosts Stake

Maryland State Retirement & Pension System raised its stake in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 40.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 12,095 shares of the medical technology company’s stock after purchasing an additional 3,486 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Teleflex were worth $1,512,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. GAMMA Investing LLC lifted its stake in shares of Teleflex by 9.8% in the third quarter. GAMMA Investing LLC now owns 921 shares of the medical technology company’s stock valued at $115,000 after buying an additional 82 shares during the period. Hsbc Holdings PLC grew its position in Teleflex by 4.7% during the first quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company’s stock worth $222,000 after buying an additional 84 shares in the last quarter. Baldwin Wealth Partners LLC MA increased its stake in Teleflex by 7.5% during the third quarter. Baldwin Wealth Partners LLC MA now owns 1,702 shares of the medical technology company’s stock valued at $213,000 after acquiring an additional 119 shares during the period. Allworth Financial LP increased its stake in Teleflex by 91.8% during the second quarter. Allworth Financial LP now owns 349 shares of the medical technology company’s stock valued at $44,000 after acquiring an additional 167 shares during the period. Finally, Kelleher Financial Advisors bought a new position in Teleflex during the second quarter valued at about $25,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Stock Performance

NYSE TFX opened at $155.00 on Monday. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $156.75. The company has a quick ratio of 1.59, a current ratio of 2.01 and a debt-to-equity ratio of 0.44. The stock has a market cap of $6.15 billion, a P/E ratio of 18.83, a PEG ratio of 1.04 and a beta of 0.85. The company’s 50-day simple moving average is $133.59 and its 200 day simple moving average is $127.37.

Teleflex (NYSE:TFX – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The medical technology company reported $2.63 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.73. The firm had revenue of $567.80 million during the quarter, compared to analysts’ expectations of $565.52 million. Teleflex had a net margin of 13.51% and a return on equity of 10.57%. The company’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter last year, the company earned $3.67 earnings per share. As a group, research analysts forecast that Teleflex Incorporated will post 7.67 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 31st. Stockholders of record on Monday, November 16th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Monday, November 16th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.9%. Teleflex’s dividend payout ratio is presently 16.52%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Truist Financial upped their price target on Teleflex from $142.00 to $167.00 and gave the company a “hold” rating in a report on Monday, November 9th. UBS Group upped their target price on Teleflex from $145.00 to $158.00 and gave the company a “neutral” rating in a research note on Tuesday, August 11th. Zacks Research cut Teleflex from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 23rd. Wells Fargo & Company raised their target price on Teleflex from $138.00 to $167.00 and gave the stock an “equal weight” rating in a research report on Friday, November 6th. Finally, Mizuho set a $160.00 price target on shares of Teleflex in a research note on Friday, November 6th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Teleflex presently has a consensus rating of “Moderate Buy” and an average price target of $163.30.

Read Our Latest Report on Teleflex

About Teleflex

(Free Report)

Teleflex is a global medical technology company that develops, manufactures and markets single-use medical devices used by healthcare professionals in hospitals and other care settings. Its products support a range of procedures, including vascular access, anesthesia, critical care, surgery, urology and emergency medicine. The company’s offerings include vascular and interventional access devices, catheters, airway management products, surgical instruments and other devices used in diagnostic and therapeutic procedures.

See Also

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.